Sales in GSK’s respiratory portfolio are currently being driven by its blockbuster anti-IL5 biologic, Nucala. The drug is approved in several countries for treating eosinophil-driven diseases ...

Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best immunology stocks to buy now.